Credit Suisse’s Aptinyx Inc. Common Stock APTX Stock Holding History

Credit Suisse’s Portfolio APTX Stock Details APTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-11,233	Closed	-$39K	–	4648
2020 Q4	$39K	Buy	+11,233	New	+$39.1K	﹤0.01%	4271

Other funds holding APTX

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Credit Suisse's APTX Position: Q1 2021 in Review

Credit Suisse sold out of Aptinyx Inc. Common Stock (APTX) in Q1 2021, closing a stake of 11,233 shares — an estimated $39K sold.

Credit Suisse first reported a position in APTX in Q4 2020 and held it in 1 quarter. The position peaked at $39K in Q4 2020. 70 funds tracked by Wall St. Rank hold APTX as of Q1 2021.

Credit Suisse reported no remaining Aptinyx Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Credit Suisse sold 11,233 Aptinyx Inc. Common Stock shares in Q1 2021, an estimated $39K.
Credit Suisse first reported a position in Aptinyx Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Credit Suisse's Aptinyx Inc. Common Stock position peaked at $39K in Q4 2020.
70 funds tracked by Wall St. Rank held Aptinyx Inc. Common Stock as of Q1 2021.

Based on Credit Suisse's 13F filing for Q1 2021, filed 14 May 2021.